AquaBounty seeks Canadian approval for biotech salmon

AquaBounty Technologies has taken the initial steps to seek approval in Canada for its biotech salmon as it awaits an FDA panel's review of the product. AquaBounty President and CEO Ronald Stotish said the Canadian application is in its early stages, but the company is "very interested because of our strong presence" in the country.

View Full Article in:

Gazette (Montreal) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC